Sam Sorof

1.4k total citations
54 papers, 1.2k citations indexed

About

Sam Sorof is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sam Sorof has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Sam Sorof's work include Liver Disease Diagnosis and Treatment (8 papers), Drug Transport and Resistance Mechanisms (6 papers) and Carcinogens and Genotoxicity Assessment (5 papers). Sam Sorof is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Drug Transport and Resistance Mechanisms (6 papers) and Carcinogens and Genotoxicity Assessment (5 papers). Sam Sorof collaborates with scholars based in United States and France. Sam Sorof's co-authors include Quentin Tonelli, Philip P. Cohen, Brahma P. Sani, Haider Raza, David M. Mott, R. Philip Custer, Frederick V. Schaefer, P. Fabisch, Tibor Keler and E. C. Miller and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Sam Sorof

54 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sam Sorof United States 20 639 321 250 175 86 54 1.2k
L. A. Stocken United Kingdom 21 774 1.2× 226 0.7× 146 0.6× 77 0.4× 87 1.0× 73 1.3k
Peter Ove United States 24 894 1.4× 190 0.6× 238 1.0× 176 1.0× 70 0.8× 54 1.7k
George Melnykovych United States 24 959 1.5× 145 0.5× 167 0.7× 130 0.7× 88 1.0× 87 1.4k
Gerald L. Sattler United States 29 925 1.4× 488 1.5× 376 1.5× 149 0.9× 111 1.3× 44 2.2k
Harry W. Chen United States 15 1.2k 1.9× 174 0.5× 188 0.8× 103 0.6× 273 3.2× 19 1.8k
Weinstein Ib United States 25 1.3k 2.0× 625 1.9× 386 1.5× 139 0.8× 44 0.5× 52 1.9k
Richard M. Halpern United States 18 717 1.1× 161 0.5× 79 0.3× 72 0.4× 157 1.8× 30 1.1k
Anders Åström Sweden 25 1.2k 1.9× 232 0.7× 139 0.6× 391 2.2× 141 1.6× 48 1.9k
P. G. Munder Germany 20 931 1.5× 180 0.6× 117 0.5× 45 0.3× 195 2.3× 52 1.4k
William C. Werkheiser United States 14 779 1.2× 167 0.5× 137 0.5× 32 0.2× 70 0.8× 24 1.2k

Countries citing papers authored by Sam Sorof

Since Specialization
Citations

This map shows the geographic impact of Sam Sorof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Sorof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Sorof more than expected).

Fields of papers citing papers by Sam Sorof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Sorof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Sorof. The network helps show where Sam Sorof may publish in the future.

Co-authorship network of co-authors of Sam Sorof

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Sorof. A scholar is included among the top collaborators of Sam Sorof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Sorof. Sam Sorof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sorof, Sam. (1994). Modulation of mitogenesis by liver fatty acid binding protein. Cancer and Metastasis Reviews. 13(3-4). 317–336. 52 indexed citations
2.
Keler, Tibor & Sam Sorof. (1993). Growth promotion of transfected hepatoma cells by liver fatty acid binding protein. Journal of Cellular Physiology. 157(1). 33–40. 32 indexed citations
3.
Raza, Haider, et al.. (1989). Specific high affinity binding of lipoxygenase metabolites of arachidonic acid by liver fatty acid binding protein. Biochemical and Biophysical Research Communications. 161(2). 448–455. 79 indexed citations
4.
Sorof, Sam, et al.. (1985). A new nucleosomal protein in normal liver related to the cytoplasmic polypeptide target of a carcinogen. Molecular and Cellular Biochemistry. 68(1). 49–57. 3 indexed citations
5.
Schaefer, Frederick V., R. Philip Custer, & Sam Sorof. (1983). Squamous metaplasia in human breast culture: induction by cyclic adenine nucleotide and prostaglandins, and influence of menstrual cycle.. PubMed. 43(1). 279–86. 23 indexed citations
6.
Feinberg, Ronald F., et al.. (1978). Carcinogen-protein complexes in hamster colon and glandular stomach during long-term administration of 3-methylcholanthrene.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(6). 1654–60. 1 indexed citations
7.
Sorof, Sam, et al.. (1977). Carcinogen-protein complexes in liver during hepatocarcinogenesis by aflatoxin B1(1).. PubMed. 37(12). 4304–12. 11 indexed citations
8.
Sorof, Sam, et al.. (1977). Evidence for a receptor protein of activated carcinogen. Proceedings of the National Academy of Sciences. 74(6). 2293–2296. 15 indexed citations
9.
Sorof, Sam, et al.. (1977). Carcinogen-protein complexes in mammary gland after administration of 3-methylcholanthrene. Biochemical and Biophysical Research Communications. 79(3). 713–719. 9 indexed citations
10.
Chibber, B A, et al.. (1975). High extracellular fibrinolytic activity of tumors and control normal tissues. Biochemical and Biophysical Research Communications. 65(2). 806–812. 18 indexed citations
11.
Mott, David M., Brahma P. Sani, & Sam Sorof. (1973). The content of the principal protein target of a hepatic carcinogen in liver tumors.. PubMed. 33(11). 2721–5. 5 indexed citations
12.
Sorof, Sam, et al.. (1973). The principal liver carcinogen-protein conjugate after a single dose of hepatic azocarcinogen.. PubMed. 33(9). 2010–3. 4 indexed citations
13.
Sorof, Sam, Valerie M. Kish, & Brahma P. Sani. (1972). Purification and properties of the principal liver protein conjugate of a hepatic carcinogen. Biochemical and Biophysical Research Communications. 48(4). 860–865. 6 indexed citations
14.
Sani, Brahma P., et al.. (1972). Detection of the principal protein target of a hepatic carcinogen. Biochemical and Biophysical Research Communications. 49(6). 1598–1604. 5 indexed citations
15.
Bakay, Bohdan, Sam Sorof, & Günther Siebert. (1969). Azoproteins of liver nuclei isolated in an aqueous or nonaqueous medium from rats fed an azocarcinogen.. PubMed. 29(1). 28–32. 4 indexed citations
16.
Bakay, Bohdan & Sam Sorof. (1969). Zonal electrophoresis of the soluble nuclear proteins of normal and preneoplastic livers.. PubMed. 29(1). 22–7. 3 indexed citations
17.
Sorof, Sam, et al.. (1969). Increased Selectivity of Interaction between Fluorenylamine Carcinogens and Liver Proteins during Hepatocarcinogenesis. Molecular Pharmacology. 5(6). 625–639. 9 indexed citations
18.
Sorof, Sam, et al.. (1958). Soluble liver h proteins during hepatocarcinogenesis by aminoazo dyes and 2-acetylaminofluorene in the rat.. Cancer Research. 18(1). 33–46. 34 indexed citations
19.
Sorof, Sam, et al.. (1954). The Single Sucrose Gradient as a Convection Barrier During Descending Boundary Preparative Electrophoresis1. Journal of the American Chemical Society. 76(18). 4740–4742. 7 indexed citations
20.
Sorof, Sam. (1953). The Use of the Schlieren Optical System for Sampling after Preparative Angle Ultracentrifugation1. Journal of the American Chemical Society. 75(21). 5443–5445. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026